Gastrointestinal impairment (GII) is acute paralysis of the GI tract beginning two to seven days after major abdominal surgery. Around 25 percent of patients develop GII due to postoperative ileus (POI), a small bowel blockage or another postoperative complication. GII puts patients at risk and leads to readmission rates exceeding 20 percent following surgery. One (read more)
License Agreement
UTRF, UTHSC, and Anviron Partner to Commercialize Novel Treatment for Pancreatic Cancer
A Mission for Making Good Medicine The University of Tennessee Research Foundation (UTRF), the University of Tennessee Health Science Center (UTHSC), and biotech therapeutics startup Anviron recently announced a partnership to commercialize a novel treatment with promising efficacy against pancreatic cancer tumors. According to the Genetic and Rare Diseases Information Center, the total number of (read more)
UTRF Startup Developing Next-Generation Devices for Endoscopy
A technology from the University of Tennessee, Knoxville, lies at the heart of a startup company creating next-generation medical devices for flexible endoscopy. EndoTheia harnesses the power of intelligently micro-machined materials to create highly dexterous manipulators, adding flexibility that increases therapeutic yields in complex endoscopic procedures. The company’s devices supplement widely used and commercially available (read more)